SK bioscience to acquire German vaccine manufacturer IDT Biologika for $470 million
SK bioscience will acquire IDT Biologika, a 440 million euro ($470 million) German vaccine contract manufacturer, the vaccine developer said Wednesday, despite ongoing group-wide rebalancing attempts.